Cargando…

Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD), caused by the loss of dystrophin, remains incurable. Reduction in muscle regeneration with DMD is associated with the accumulation of fibroadipogenic progenitors (FAPs) differentiating into myofibroblasts and leading to a buildup of the collagenous tissue aggravati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Zhanguo, Lu, Aiping, Daquinag, Alexes C., Yu, Yongmei, Huard, Matthieu, Tseng, Chieh, Gao, Xueqin, Huard, Johnny, Kolonin, Mikhail G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534118/ https://www.ncbi.nlm.nih.gov/pubmed/34680151 http://dx.doi.org/10.3390/biom11101519

Ejemplares similares

Endothelial TrkA coordinates vascularization and innervation in thermogenic adipose tissue and can be targeted to control metabolism
por: Daquinag, Alexes C., et al.
Publicado: (2022)

Heterogenetic parabiosis between healthy and dystrophic mice improve the histopathology in muscular dystrophy
por: Lu, Aiping, et al.
Publicado: (2020)

The role of the aging microenvironment on the fate of PDGFRβ lineage cells in skeletal muscle repair
por: Lu, Aiping, et al.
Publicado: (2022)

Glycosaminoglycan Modification of Decorin Depends on MMP14 Activity and Regulates Collagen Assembly
por: Daquinag, Alexes C., et al.
Publicado: (2020)

Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
por: He, Ruojie, et al.
Publicado: (2020)

Poster 206: TIPE2 Mitigates the Histopathology of Osteoarthritis in An Accelerate Aging Mouse Model
por: Huard, Matthieu, et al.
Publicado: (2022)

Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
por: Huard, Johnny, et al.
Publicado: (2022)

Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients
por: Meyer, Pierre, et al.
Publicado: (2021)

Catheter Ablation of Multiple Accessory Pathways in Duchenne Muscular Dystrophy
por: Finsterer, Josef, et al.
Publicado: (2013)

Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
por: Dort, Junio, et al.
Publicado: (2021)

Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
por: Huard, Johnny, et al.
Publicado: (2022)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Clinical utility of serum biomarkers in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2016)

Bone morphogenetic protein 4 rescues the bone regenerative potential of old muscle-derived stem cells via regulation of cell cycle inhibitors
por: Cheng, Haizi, et al.
Publicado: (2022)

Fatty acid mobilization from adipose tissue is mediated by CD36 posttranslational modifications and intracellular trafficking
por: Daquinag, Alexes C., et al.
Publicado: (2021)

Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy
por: Klimczak, Aleksandra, et al.
Publicado: (2020)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Family reflections: Duchenne Muscular Dystrophy
por: Gill, Omaira
Publicado: (2022)

Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Effect of Yoga and Ayurveda on Duchenne Muscular Dystrophy
por: Telles, Shirley, et al.
Publicado: (2011)

Symptomatic therapy of Duchenne Muscular Dystrophy (DMD)
por: Rüdel, Reinhardt
Publicado: (2012)

Presence of mechanical dyssynchrony in duchenne muscular dystrophy
por: Hor, Kan N, et al.
Publicado: (2011)

Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy
por: Kharraz, Yacine, et al.
Publicado: (2014)

Duchenne muscular dystrophy: Advances in molecular appraoch
por: Benitto, Afaf, et al.
Publicado: (2013)

Left ventricular noncompaction in Duchenne muscular dystrophy
por: Statile, Christopher J, et al.
Publicado: (2013)

Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nbin2hdugjs62ig0278k71697q